secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001558370-24-001573
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path Holdings announces 1-for-20 reverse stock split effective Feb 22, 2024
-------------------------------------------------------------------------------

- Reverse split ratio 1-for-20 effective 5:30 p.m. ET Feb 22, 2024; trading starts split-adjusted on Nasdaq under BPTH on Feb 23.
- Shares outstanding reduced from ~12.35M to ~617,833; no fractional shares issued.
- New CUSIP number 09057N409; par value unchanged; all options/warrants adjusted.
- Company uses DNAbilize antisense RNAi nanoparticle tech for cancer drugs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/0001558370-24-001573-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/bpth-20240221x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-001573

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer